metastatic cutaneous squamous cell carcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 2 (1)

Interventional (2)

Emory University (1)
H. Lee Moffitt Cancer Center and Research Institute (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadadrenal insufficiency

I am/have/hadmetastatic cutaneous squamous cell carcinoma

I am/have/hadacquired immunodeficiency syndrome (aids)

I am/have/hadcancer therapy

I am/have/hadlymphoma

I am/have/hadneutrophil count

I am/have/hadmajor surgery

I am/have/hadprimary lesion

I am/have/hadhypothyroidism

I am/have/hadsquamous cell carcinoma

I am/have/hadmultiple myeloma

I am/have/hadhair thinning

I am/have/hadextranodal extension

I am/have/hadcarcinoma

I am/have/hadcancer

I am/have/hadhormone replacement therapy

I am/have/hadmonoclonal antibody therapy

I am/have/hadinternational normalized ratio

I am/have/hadoophorectomy

I am/have/hadhodgkin's disease

added new label for I am/have/had

more

I am looking for

I am looking forprednisone

I am looking forheparin

I am looking formonoclonal antibodies

I am looking forcemiplimab

I am looking forfollicle stimulating hormone

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

The purpose of this research study is to determine how people with weakened immune systems and unresectable (cannot be removed by surgery) locally recurrent and/or metastatic cutaneous squamous cell carcinoma (CSCC) respond to study treatment with Cemiplimab. Cemiplimab is approved for sale in United States by the U.S.

cancer

metastatic cutaneous squamous cell carcinoma

squamous cell carcinoma of the skin

lymphoma

multiple myeloma

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

This phase I trial studies how well cemiplimab before and after surgery works in treating patients with high risk cutaneous squamous cell cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

adrenal insufficiency

heparin

cancer therapy

neutrophil count

major surgery

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.